Similarly, the side effects that LEP and LEPR share with selective serotonin inhibitors such as “food craving”, “binge eating”, “hyperphagia” and “obesity” (Fig 3a) suggest a connection between serotonin signalling and leptin. This evidence concerns the gene LEPR and obesity disorder.